↑ Rising
Business
Novartis’s Latest Trial Setback Sinks Stock
Novartis shares drop significantly following multiple trial setbacks and difficult dealmaking in the pharmaceutical sector.
Pharma
5 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
Vertex Pharma's $10 billion purchase of Crinetics sparks a near‑doubling of its shares and a biotech‑M&A surge
◼ Archived
Business
🔮 fades
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.